The Blood Matters program is underpinned by the Department’s values, vision, and priorities. Read more about the priorities on the Our priorities page.
The program aims to support best practice in all areas related to blood management safety and governance.
The content of these pages is intended for use by health care staff; clinical, quality, and scientific.
What's new
-
The STIR annual report 2023-24 provides detailed information on the number and types of blood and blood product adverse events for the 2023-24 financial year.
Serious Transfusion Incident Report – Blood Matters annual report 2023-24The summary report 2023-24 provides a snapshot of the blood and blood product adverse events for the year.
Serious Transfusion Incident Report – Blood Matters summary report 2023-24All annual and summary reports are available at Serious Transfusion Incident Reporting system (STIR).
-
This STIR bulletin focuses on the risks and mitigation strategies to help prevent TACO in susceptible patients.
STIR bulletin No. 13 – Transfusion Associated Circulatory Overload (TACO) mitigation strategiesAll STIR bulletins are available at Serious Transfusion Incident Reporting system (STIR).
-
O RhD negative red blood cell (RBC) audit report is now available.
The audit was conducted in 2 parts:
- Part A was health service policy
- Part B was a retrospective audit of the fate all O RhD RBC issued during March 2024.
O RhD negative red blood cell (RBC) audit reportO RhD negative red blood cell (RBC) audit reportSee more at Blood Matters program - audit reports.
-
The 2025 audit focuses on the pretransfusion patient identification and product check. Details of the audit are now available on Blood Matters audits.
-
Following the release of Beriplex, a four-factor prothrombin complex concentrate, there has been an update to the recommendations for warfarin reversal.
For more information, see Clinical education resources on Resources and education – blood transfusion.
Reviewed 16 September 2025